Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002012250 | SCV002227919 | uncertain significance | not provided | 2022-02-28 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. This variant has not been reported in the literature in individuals affected with OBSL1-related conditions. This variant is present in population databases (rs568750433, gnomAD 0.01%). This sequence change creates a premature translational stop signal (p.Arg1485*) in the OBSL1 gene. However, it is currently unclear if variants that occur in this region of the gene cause disease. |
Ce |
RCV002012250 | SCV004151473 | uncertain significance | not provided | 2023-10-01 | criteria provided, single submitter | clinical testing | OBSL1: PM2, PVS1:Moderate |
Center for Genomic Medicine, |
RCV003989136 | SCV004805858 | likely pathogenic | 3M syndrome 2 | 2024-03-29 | criteria provided, single submitter | clinical testing |